DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Par Drugs and Chemicals Limited — Board Meeting Intimation

NSE 55 min ago·19 Oct 2026, 10:35 am

Par Drugs And Chemicals

Par Drugs and Chemicals Limited has announced that its board will meet on October 29, 2026, to review and approve the company's unaudited financial results for the first half of the fiscal year ending September 2026.

This announcement is significant for investors as it provides the first official insight into the company's performance during this period. The results will reflect the company's operational efficiency, sales growth, and profitability, offering a crucial update for those tracking the stock.

Investors should watch for the release of these results and the management's commentary on future outlook. The data will help determine if the stock is on a growth trajectory or facing headwinds, guiding investment decisions.